Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin

American Journal of Surgical Pathology

Volumn 23, Issue 7, 1999, Pages 822-828

  Blaheta, Hans Juergen ^a   Schittek, Birgit ^a   Breuninger, Helmut ^a   Sotlar, Karl ^a   Ellwanger, Ulf ^a   Thelen, Marcel H ^a   Maczey, Evi ^a   Rassner, Gernot ^a   Bueltmann, Burkhard ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Immunohistochemistry; Melanoma; Regional lymph node micrometastasis; Reverse transcription polymerase chain reaction; Sentinel node; Tumor thickness

Indexed keywords

ANTIBODY; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGED; BLOTTING, SOUTHERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0033018112     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199907000-00011     Document Type: Article

References (25)

1. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 1988;6: 163-72.
2. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-63.
3. Battayani Z, Grob JJ, Xerri L, et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995;131:443-7.
4. Bautista NC, Cohen S, Anders KH. Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 1994;102:102-8.
5. Bell ME, Hill DP, Bhargava MK. Lymphatic invasion in pigmented nevi. Am J Clin Pathol 1979;72:97-100.
6. Blaheta H-J, Schittek B, Breuninger H, et al. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer 1998;79:318-323.
7. Carson KF, Wen DR, Li PX, Lana AMA, Bailly C, Morton DL, Cochran AJ. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
9. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study [see comments]. Am J Surg Pathol 1988;12:612-8.
10. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988;263:15335-41.
11. Gardner MJ, Altmann DG. Statistics with confidence. BMJ 1989;71-79.
12. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
13. Kunter U, Buer J, Probst M, et al. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma [see comments]. J Natl Cancer Inst 1996;88:590-4.
14. Kwon BS, Haq AK, Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci U S A 1987;84:7473-7.
15. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-6.
16. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
17. Reintgen D. More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques. Curr Opin Oncol 1996;8:152-8.
18. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
19. Ridolfi RL, Rosen PP, Thaler H. Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer 1977;39:164-71.
20. Ross MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. New York: Cold Spring Harbor Laboratory, 1989.
22. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-9.
23. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
24. Van der Velde Zimmermann D, Roijers JF, Bouwens Rombouts A, De Weger RA, De Graaf PW, Tilanus MG, Van den Tweel JG. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759-64.
25. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.